EP2576747B1 - Hard surface treatment composition - Google Patents
Hard surface treatment composition Download PDFInfo
- Publication number
- EP2576747B1 EP2576747B1 EP11719579.2A EP11719579A EP2576747B1 EP 2576747 B1 EP2576747 B1 EP 2576747B1 EP 11719579 A EP11719579 A EP 11719579A EP 2576747 B1 EP2576747 B1 EP 2576747B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- polymer
- composition
- group
- copolymers
- homopolymers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 77
- 238000004381 surface treatment Methods 0.000 title claims description 7
- 229920000642 polymer Polymers 0.000 claims description 87
- 239000000341 volatile oil Substances 0.000 claims description 36
- 229920001577 copolymer Polymers 0.000 claims description 32
- 229920001519 homopolymer Polymers 0.000 claims description 30
- 230000000845 anti-microbial effect Effects 0.000 claims description 24
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 16
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 16
- 230000003115 biocidal effect Effects 0.000 claims description 13
- 239000003139 biocide Substances 0.000 claims description 12
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 12
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 10
- 239000004599 antimicrobial Substances 0.000 claims description 10
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 10
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 claims description 10
- -1 tert butyl cresol Chemical compound 0.000 claims description 9
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 8
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 claims description 8
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims description 8
- 239000005770 Eugenol Substances 0.000 claims description 8
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 8
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 8
- 239000005844 Thymol Substances 0.000 claims description 8
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 8
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 claims description 8
- 229960002217 eugenol Drugs 0.000 claims description 8
- 229940116411 terpineol Drugs 0.000 claims description 8
- 229960000790 thymol Drugs 0.000 claims description 8
- 125000002947 alkylene group Chemical group 0.000 claims description 7
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims description 7
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 claims description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 claims description 6
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 claims description 4
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 claims description 4
- WRFXXJKURVTLSY-UHFFFAOYSA-N 2,6-dimethyloctan-2-ol Chemical compound CCC(C)CCCC(C)(C)O WRFXXJKURVTLSY-UHFFFAOYSA-N 0.000 claims description 4
- PXIKRTCSSLJURC-UHFFFAOYSA-N Dihydroeugenol Chemical compound CCCC1=CC=C(O)C(OC)=C1 PXIKRTCSSLJURC-UHFFFAOYSA-N 0.000 claims description 4
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 claims description 4
- 229960005233 cineole Drugs 0.000 claims description 4
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 claims description 4
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 claims description 4
- NNRLDGQZIVUQTE-UHFFFAOYSA-N gamma-Terpineol Chemical compound CC(C)=C1CCC(C)(O)CC1 NNRLDGQZIVUQTE-UHFFFAOYSA-N 0.000 claims description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 4
- NNWHUJCUHAELCL-SNAWJCMRSA-N trans-isomethyleugenol Chemical compound COC1=CC=C(\C=C\C)C=C1OC NNWHUJCUHAELCL-SNAWJCMRSA-N 0.000 claims description 4
- YHQGMYUVUMAZJR-UHFFFAOYSA-N α-terpinene Chemical compound CC(C)C1=CC=C(C)CC1 YHQGMYUVUMAZJR-UHFFFAOYSA-N 0.000 claims description 4
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 claims description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 2
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 claims description 2
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 claims description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims description 2
- FQTLCLSUCSAZDY-QKXCFHHRSA-N (3S,6Z)-nerolidol Chemical compound CC(C)=CCC\C(C)=C/CC[C@](C)(O)C=C FQTLCLSUCSAZDY-QKXCFHHRSA-N 0.000 claims description 2
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 claims description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims description 2
- WRYLYDPHFGVWKC-SNVBAGLBSA-N 4-Terpineol Natural products CC(C)[C@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-SNVBAGLBSA-N 0.000 claims description 2
- KVNINXUPDUASFF-UHFFFAOYSA-N C(CCCCC)C1=C(C(=CC(=C1)CC=C)OC)O Chemical compound C(CCCCC)C1=C(C(=CC(=C1)CC=C)OC)O KVNINXUPDUASFF-UHFFFAOYSA-N 0.000 claims description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 2
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims description 2
- 241000134874 Geraniales Species 0.000 claims description 2
- 239000005792 Geraniol Substances 0.000 claims description 2
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 2
- DUKPKQFHJQGTGU-UHFFFAOYSA-N Hexyl salicylic acid Chemical compound CCCCCCOC(=O)C1=CC=CC=C1O DUKPKQFHJQGTGU-UHFFFAOYSA-N 0.000 claims description 2
- OJLMARCQPSGYNE-UXBLZVDNSA-N Isocitral Chemical compound CC(C)=CC\C=C(/C)CC=O OJLMARCQPSGYNE-UXBLZVDNSA-N 0.000 claims description 2
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 claims description 2
- ZPUKHRHPJKNORC-UHFFFAOYSA-N Longifolene Natural products CC1(C)CCCC2(C)C3CCC1(C3)C2=C ZPUKHRHPJKNORC-UHFFFAOYSA-N 0.000 claims description 2
- PDSNLYSELAIEBU-UHFFFAOYSA-N Longifolene Chemical compound C1CCC(C)(C)C2C3CCC2C1(C)C3=C PDSNLYSELAIEBU-UHFFFAOYSA-N 0.000 claims description 2
- WSTYNZDAOAEEKG-UHFFFAOYSA-N Mayol Natural products CC1=C(O)C(=O)C=C2C(CCC3(C4CC(C(CC4(CCC33C)C)=O)C)C)(C)C3=CC=C21 WSTYNZDAOAEEKG-UHFFFAOYSA-N 0.000 claims description 2
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 claims description 2
- GUUHFMWKWLOQMM-NTCAYCPXSA-N alpha-hexylcinnamaldehyde Chemical compound CCCCCC\C(C=O)=C/C1=CC=CC=C1 GUUHFMWKWLOQMM-NTCAYCPXSA-N 0.000 claims description 2
- GUUHFMWKWLOQMM-UHFFFAOYSA-N alpha-n-hexylcinnamic aldehyde Natural products CCCCCCC(C=O)=CC1=CC=CC=C1 GUUHFMWKWLOQMM-UHFFFAOYSA-N 0.000 claims description 2
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 claims description 2
- 229940062909 amyl salicylate Drugs 0.000 claims description 2
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 claims description 2
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 claims description 2
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 claims description 2
- 235000007746 carvacrol Nutrition 0.000 claims description 2
- IRAQOCYXUMOFCW-CXTNEJHOSA-N cedrene Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@H]1C(C)=CC2 IRAQOCYXUMOFCW-CXTNEJHOSA-N 0.000 claims description 2
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 claims description 2
- NNWHUJCUHAELCL-UHFFFAOYSA-N cis-Methyl isoeugenol Natural products COC1=CC=C(C=CC)C=C1OC NNWHUJCUHAELCL-UHFFFAOYSA-N 0.000 claims description 2
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 claims description 2
- RBNWAMSGVWEHFP-UHFFFAOYSA-N cis-p-Menthan-1,8-diol Natural products CC(C)(O)C1CCC(C)(O)CC1 RBNWAMSGVWEHFP-UHFFFAOYSA-N 0.000 claims description 2
- 229940043350 citral Drugs 0.000 claims description 2
- WTEVQBCEXWBHNA-YFHOEESVSA-N citral B Natural products CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 claims description 2
- 229930003633 citronellal Natural products 0.000 claims description 2
- 235000000983 citronellal Nutrition 0.000 claims description 2
- 235000000484 citronellol Nutrition 0.000 claims description 2
- 229930003836 cresol Natural products 0.000 claims description 2
- 229930007927 cymene Natural products 0.000 claims description 2
- IRAQOCYXUMOFCW-UHFFFAOYSA-N di-epi-alpha-cedrene Natural products C1C23C(C)CCC3C(C)(C)C1C(C)=CC2 IRAQOCYXUMOFCW-UHFFFAOYSA-N 0.000 claims description 2
- 229930008394 dihydromyrcenol Natural products 0.000 claims description 2
- XSNQECSCDATQEL-UHFFFAOYSA-N dihydromyrcenol Chemical compound C=CC(C)CCCC(C)(C)O XSNQECSCDATQEL-UHFFFAOYSA-N 0.000 claims description 2
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 claims description 2
- 229940043259 farnesol Drugs 0.000 claims description 2
- 229930002886 farnesol Natural products 0.000 claims description 2
- 229940113087 geraniol Drugs 0.000 claims description 2
- WPFVBOQKRVRMJB-UHFFFAOYSA-N hydroxycitronellal Chemical compound O=CCC(C)CCCC(C)(C)O WPFVBOQKRVRMJB-UHFFFAOYSA-N 0.000 claims description 2
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 claims description 2
- 235000001510 limonene Nutrition 0.000 claims description 2
- 229940087305 limonene Drugs 0.000 claims description 2
- 229930007744 linalool Natural products 0.000 claims description 2
- 229940041616 menthol Drugs 0.000 claims description 2
- 229960001047 methyl salicylate Drugs 0.000 claims description 2
- 229940116837 methyleugenol Drugs 0.000 claims description 2
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 claims description 2
- 229930008383 myrcenol Natural products 0.000 claims description 2
- DUNCVNHORHNONW-UHFFFAOYSA-N myrcenol Chemical compound CC(C)(O)CCCC(=C)C=C DUNCVNHORHNONW-UHFFFAOYSA-N 0.000 claims description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 claims description 2
- 229930006978 terpinene Natural products 0.000 claims description 2
- 150000003507 terpinene derivatives Chemical class 0.000 claims description 2
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 claims description 2
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 claims description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims description 2
- 235000012141 vanillin Nutrition 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 description 20
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 241000588724 Escherichia coli Species 0.000 description 11
- 238000004140 cleaning Methods 0.000 description 9
- 239000004584 polyacrylic acid Substances 0.000 description 9
- 230000008901 benefit Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 229960000686 benzalkonium chloride Drugs 0.000 description 5
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 5
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical group Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 241000194029 Enterococcus hirae Species 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 description 3
- 229940068984 polyvinyl alcohol Drugs 0.000 description 3
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NHGXDBSUJJNIRV-UHFFFAOYSA-M tetrabutylammonium chloride Chemical compound [Cl-].CCCC[N+](CCCC)(CCCC)CCCC NHGXDBSUJJNIRV-UHFFFAOYSA-M 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- GKQHIYSTBXDYNQ-UHFFFAOYSA-M 1-dodecylpyridin-1-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+]1=CC=CC=C1 GKQHIYSTBXDYNQ-UHFFFAOYSA-M 0.000 description 1
- ZCPPLZJPPBIWRU-UHFFFAOYSA-M 1-hexadecyl-3-methylimidazol-3-ium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCN1C=C[N+](C)=C1 ZCPPLZJPPBIWRU-UHFFFAOYSA-M 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000164439 Curcuma angustifolia Species 0.000 description 1
- RUPBZQFQVRMKDG-UHFFFAOYSA-M Didecyldimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC RUPBZQFQVRMKDG-UHFFFAOYSA-M 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000003842 bromide salts Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 description 1
- 229960004670 didecyldimethylammonium chloride Drugs 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000191 poly(N-vinyl pyrrolidone) Polymers 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- QAZCPUUJMFBNJO-UHFFFAOYSA-N pyrrolidin-2-one;sodium Chemical compound [Na].O=C1CCCN1 QAZCPUUJMFBNJO-UHFFFAOYSA-N 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- VMJQVRWCDVLJSI-UHFFFAOYSA-M tetraheptylazanium;chloride Chemical compound [Cl-].CCCCCCC[N+](CCCCCCC)(CCCCCCC)CCCCCCC VMJQVRWCDVLJSI-UHFFFAOYSA-M 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- CEYYIKYYFSTQRU-UHFFFAOYSA-M trimethyl(tetradecyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCC[N+](C)(C)C CEYYIKYYFSTQRU-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/18—Hydrocarbons
- C11D3/188—Terpenes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2003—Alcohols; Phenols
- C11D3/2006—Monohydric alcohols
- C11D3/2034—Monohydric alcohols aromatic
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2003—Alcohols; Phenols
- C11D3/2006—Monohydric alcohols
- C11D3/2037—Terpenes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2003—Alcohols; Phenols
- C11D3/2041—Dihydric alcohols
- C11D3/2062—Terpene
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2068—Ethers
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2072—Aldehydes-ketones
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2093—Esters; Carbonates
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/22—Carbohydrates or derivatives thereof
- C11D3/222—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/22—Carbohydrates or derivatives thereof
- C11D3/222—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
- C11D3/225—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin etherified, e.g. CMC
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3707—Polyethers, e.g. polyalkyleneoxides
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3746—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3753—Polyvinylalcohol; Ethers or esters thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3746—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3757—(Co)polymerised carboxylic acids, -anhydrides, -esters in solid and liquid compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3746—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3769—(Co)polymerised monomers containing nitrogen, e.g. carbonamides, nitriles or amines
- C11D3/3776—Heterocyclic compounds, e.g. lactam
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/50—Perfumes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/24—Hydrocarbons
- C11D7/248—Terpenes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/261—Alcohols; Phenols
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/263—Ethers
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/264—Aldehydes; Ketones; Acetals or ketals
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
- C11D7/266—Esters or carbonates
Definitions
- the invention is in the field of hard surface cleaning, especially in the field of hard surface cleaning composition having anti-microbial effect.
- Hygiene is of high priority to present day consumers. Consumers all over the world use various kinds of disinfecting cleaning compositions for hard surfaces.
- E . coli Escherichia coli
- Staphylococcus aureus also referred to as S . aureus.
- S . aureus Several other gram-positive and gram-negative bacteria can be found on any household surface.
- hypochlorite The most commonly known disinfectant in house hold care is hypochlorite.
- hypochlorite causes bad smell, bleaches clothes that come in contact with it and is unpleasant to skin mostly caused by its high alkalinity.
- EP-A-912678 discloses the use of essential oil compounds for anti microbial effect on hard surfaces.
- essential oils are relatively expensive ingredients. Additionally, essential oils are also known for their fragrances; using high amounts may cause a peculiar smell that is not always appreciated by the consumer.
- WO1998/20735 (Procter and Gamble) describes a spray-able liquid disinfecting composition comprising a hydrogen peroxide, an antimicrobial essential oil, and a shear thinning polymeric thickener.
- the hydrogen peroxide in presence shear thinning polymeric thickener provides safe and effective disinfection on clean surfaces.
- the Application doesn't disclose a composition comprising a polymer complex and an antimicrobial composition.
- the hygiene benefit is not only active shortly after deposition, but remains on the surface for a longer time.
- composition that is effective against common bacteria, including both gram-positive and gram-negative bacteria.
- composition comprising a low amount of essential oil and quaternary ammonium biocide and a polymer complex provides improved hygiene efficacy.
- the present invention provides in a first aspect a hard surface treatment composition
- a hard surface treatment composition comprising a polymer complex comprising polymer A selected from the group of homopolymers and copolymers of carboxylic acid, and a polymer B selected from the group of homopolymers and copolymers of alkylene oxides, vinyl pyrrolidone; and/or the group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose, wherein polymer A and polymer B are not of the same class and wherein Polymer B has a monomeric unit comprising a group that forms hydrogen bonds with the carboxyl groups of polymer A; and an antimicrobial composition comprising essential oil and a quaternary ammonium biocide, wherein the pH of the hard surface treatment composition is between 2 and less than 6.
- the invention provides a method for providing an anti-microbial effect to a hard surface comprising the steps of applying a composition according to the first aspect to the surface, and waiting for at least 5 seconds.
- the invention provides the use of a combination of a polymer complex comprising polymer A selected from the group of homopolymers and copolymers of carboxylic acid, and a polymer B selected from the group of homopolymers and copolymers of alkylene oxides, vinyl pyrrolidone; and/or the group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose; wherein polymer A and polymer B are not of the same class and wherein polymer B has a monomeric unit comprising a group that forms hydrogen bonds with the carboxyl groups of polymer A; and an antimicrobial composition comprising essential oil and a quaternary ammonium biocide, wherein the pH of the hard surface treatment composition is between 2 and less than 6, for providing a anti-microbial effect on hard surfaces.
- anti-microbial effect is meant being able to kill bacteria under the standard European suspension test (EST) - EN 1276.
- composition according to the invention thus comprises a polymer complex and an antimicrobial composition.
- the polymer complex according to the invention comprises a polymer A selected from the group of homopolymers and copolymers of carboxylic acid, and a polymer B selected from the group of homopolymers and copolymers of alkylene oxides, vinyl pyrrolidone ; and/or the group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose ;
- composition according to the invention comprises a polymer A and a polymer B.
- Polymers A and B are typically selected such that they form a complex due to the formation of hydrogen bonds.
- the polymers may be homo polymers or copolymers, wherein by copolymer of monomer X is meant any polymer that contains the monomer X and at least one further monomer.
- Polymers A and B are preferably present in the composition in a ratio of between 1:5 and 5:1, more preferably between 1:2 and 2:1
- polymer A is a polymer selected from the group of homopolymers and copolymers of carboxylic acid.
- Polymer A has a plurality of carboxyl groups.
- the polymer A has a molecular mass preferably from 300 to 10 9 D (Dalton, also referred to as atomic mass units, amu).
- the polymer A is selected from the class consisting of homopolymers or copolymers of carboxylic polymers, including natural synthetic and semi-synthetic polymers in this class.
- polymer A according to the present invention include:
- Homopolymers or copolymers of carboxylic acid have a molecular mass of preferably from 2x10 3 to 10 7 D more preferably from 5x10 4 to 10 6 D and most preferably from 9x10 4 to 5x10 5 D.
- the particle size is preferably less than 200 ⁇ m, preferably less than 100 ⁇ m, more preferably less than 50 ⁇ m still more preferably less than 10 ⁇ m, or even less than 5 ⁇ m.
- the homopolymers or copolymers of polysaccharide have a molecular mass of preferably from 10 3 to 10 9 D, more preferably from 10 4 to 10 9 D and most preferably from 10 5 to 10 9 D.
- Polymer A is preferably at least partially neutralised in the Sodium (Na + ) form, preferably at least 10%w of polymer A is neutralised, more preferably at least 20%, still more preferably at least 50%.
- Polymer A may be synthetic, semi-synthetic or natural. However, synthetic or semi-synthetic polymers are preferred.
- Polymer A is preferably water soluble or water dispersible, most preferably polymer A is water soluble.
- the polymer A is selected from a class consisting of homopolymers or copolymers of carboxylic acid.
- the homopolymers or copolymers of carboxylic acid are preferably a polyacrylic acid or a copolymer thereof.
- Examples include SOKALAN® PA (BASF) and CARBOPOL® (Lubrizol).
- the concentration of polymer A in the composition according to the invention is preferably between 0.001 and 25% by weight, more preferably at least 0.002%, or even at least 0.005%, but preferably not more than 15%, more preferably less than 5%, still more preferably less than 1%, even more preferably less than 0.5%, even less than 0.1%, or even less than 0.05% by weight of the composition.
- polymer B has a monomeric unit comprising a group that forms hydrogen bonds with the carboxyl groups of polymer A.
- polymer B is selected from the group of homopolymers and copolymers of alkylene oxides, vinyl pyrrolidone; and/or the group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose.
- the group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose, is generally not water soluble.
- the particle size is set such that the particles are easily dispersible in water or and aqueous solution (i.e. a wash or rinse liquor). If the polymers are in particulate form, the particle size is preferably less than 200 ⁇ m, more preferably less than 100 ⁇ m, even more preferably less than 50 ⁇ m still more preferably less than 10 ⁇ m, or even less than 5 ⁇ m.
- polymer A and polymer B are not of the same class.
- Polymers A and B are selected from different classes of polymers. Without wishing to be limited by theory, it is believed that the two polymers A and B, when dissolved in water, form a complex with a solubility lower than each of the polymers A and B, which helps in enhanced deposition and other benefits.
- Polymer B preferably has a molecular mass from 10 3 to 10 9 D.
- Homopolymers or copolymers of vinyl pyrrolidone or vinyl alcohol preferably have a molecular mass of between 10 3 and 10 7 D, more preferably from 10 4 to 10 6 D and most preferably from 30,000 to 500,000 D.
- Commercially available polyvinyl pyrrolidone can be used, one example of which is LUVISKOL® (BASF).
- Homopolymers or copolymers of poly alkylene oxide preferably have a molecular mass greater than 2x10 4 D.
- the molecular mass is preferably from 2x10 4 to 10 6 D, more preferably from 3x10 4 to 5x10 5 D and most preferably from 5x10 4 to 2x10 5 D.
- Homopolymers or copolymers of saccharide preferably have a molecular mass of preferably from 10 3 to 10 9 D, more preferably from 10 4 to 10 9 D and most preferably from 10 5 to 10 9 D.
- Any commercially available poly alkylene oxide, for example POLYOX® (Dow Chemical Co) can be used according to the present invention.
- Polymer B may be synthetic, semi-synthetic or natural. However, synthetic or semi-synthetic polymers are preferred.
- the polymer B is water soluble.
- the polymer B is selected from a class consisting of homopolymers or copolymers of vinyl pyrrolidone or alkylene oxide.
- the concentration of polymer B in the composition according to the invention is preferably between 0.001 and 20% by weight, more preferably at least 0.002%, or even at least 0.005%, but preferably not more than 10%, more preferably less than 5%, still more preferably less than 1%, even more preferably less than 0.5%, even less than 0.1 %, or even less than 0.05% by weight of the composition.
- the most preferred combinations of the polymers are PAA-PVP, PAA-PEO, PAA-PEG Starch-graft-polymethacrylic acid-Polyethylene Oxide.
- the polymer complex according to the invention comprises an antimicrobial composition comprising essential oil and quaternary ammonium biocide.
- Essential oils are typically concentrated, hydrophobic liquid containing volatile aroma compounds from plants.
- Essential oils are also known as volatile, ethereal oils or aetherolea.
- An oil is "essential” in the sense that it carries a distinctive scent, or essence, of the plant.
- Essential oils do not as, a group, need to have any specific chemical properties in common, beyond conveying characteristic fragrances.
- Essential oils may also be obtained though synthetic or semi-synthetic routes.
- Essential oils are generally extracted by distillation. Other processes include expression, or solvent extraction. They are used in perfumes, cosmetics, soap and other products, for flavoring food and drink, and for scenting incense and household cleaning products.
- aromatic essential oils suitable for use in the present invention include amyl salicylate, carvacrol, cymene, e.g. p-cymene, dihydroeugenol, eugenol, hexyl eugenol, hexyl salicylate, isoeugenol, methyl eugenol, methyl isoeugenol, methyl salicylate, tert butyl cresol, thymol, and vanillin.
- non-aromatic essential oils of terpenoid compounds include cedrene, cineole, citral (including geranial and neral), citronellal, citronellol, eucalyptol (also known as 1,8 cineole) paradihydrolinalool, dihydromyrcenol (DH myrcenol), farnesol, geraniol, hexyl cinnamaldehyde, hydroxycitronallol, hydroxycitronellal, isocitral, limonene, preferably d-limonene, linalool, longifolene, menthol, nerol, nerolidiol, pinene, e.g.
- ⁇ -pinene phellendrene
- terpinene e.g. ⁇ -terpinene and ⁇ -terpinene
- terpineol e.g. ⁇ -terpineol and terpin-4-ol
- THM tetrahydromyrcenol
- the most preferred essential oils in the context of the present invention are thymol, terpineol and eugenol.
- the essential oil is preferably present in the composition in a concentration of between 0.001 and 10% by weight of the composition, but preferably at least 0.002%, or even at least 0.005% by weight of the composition, while preferably not more than 5%, more preferably not more than 1%, still more preferably not more than 0.5%, or even not more than 0.1% by weight of the concentration.
- composition comprises a second essential oil, wherein the essential oils are even more preferably selected from any combination of a thymol, a terpineol and/or a eugenol.
- composition comprises three essential oils, wherein the essential oils are still more preferably selected from a combination of a thymol, a terpineol and a eugenol.
- the above mentioned concentrations may be considered to be the concentrations of the combined essential oils, but preferably relate to each of the individual essential oils.
- a quaternary ammonium biocide is used to provide additional biocidal efficacy.
- the quaternary ammonium biocide is preferably selected from Cetyl-trimethyl-ammonium Chloride, Cetyl-trimethyl-ammonium Bromide, Tetradecyl-trimethyl-ammonium Chloride, Dodecyl-trimethyl-ammonium Chloride, Stearyl-trimethyl-ammonium Chloride, Octadecyl-trimethyl-ammonium Chloride, Dodecylpyridinium Chloride, Cetylpyridinium Chloride, Benzalkonium Chloride, Tetrabutyl-ammonium Chloride, Tetraheptyl-ammonium Chloride, 1,3-Decyl-2-methyl-imidazolium Chloride, 1-Hexadecyl-3-methyl-imidazolium Chloride, Didecyl-dimethyl-ammonium Bromide, Didecy
- Bromides are typically not preferred due to their toxicity.
- the most preferred quaternary ammonium biocide is benzalkonium chloride and cetylpyridinium chloride.
- the quaternary ammonium biocide is preferably present in the composition in a concentration of between 0.01 and 10% by weight of the composition, but preferably at least 0.02%, or even at least 0.05% by weight of the composition, while preferably not more than 5%, more preferably not more than 1%, still more preferably not more than 0.5%, or even not more than 0.1% by weight of the concentration.
- the quaternary ammonium biocide provides more complete kill with longer lasting hygiene.
- compositions according to the invention may be applied in various hard surface cleaning composition, such as concentrated and dilute liquid compositions.
- Concentrated composition include amongst other floor cleaner composition that need to be diluted by the consumers upon use.
- concentrations are relating to the diluted concentrations as used by the consumer.
- Dilute liquid compositions include but are not limited to ready-to-use compositions, such as liquid abrasive cleaners and toilet cleaning compositions, and spray compositions for glass, kitchen surfaces and bathroom surfaces
- the contact time of the product with the surface before rinsing is at least 5 seconds, more preferably at least 10 seconds, still more preferably at least 15 seconds, or even at least 20 seconds.
- compositions may stay for a longer period of time, preferably at least 5 minute, more preferably at least 15 minutes, still more preferably at least 1 hour, still more preferably at least 2 hours, or even more than 5 hours, or even days.
- the pH of the compositions is between pH 2 and less than pH 6, still more preferably at least pH 3.
- composition is not wiped away or rinsed, but may be wiped of after the indicated time.
- Example 1 EST challenge This test is not a surface test. It is a suspension test
- the standard European suspension test (EST) protocol - EN 1276 for antiseptics was followed.
- the test organisms were Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Enterococcus hirae. Under clean conditions the test was done with 0.03% BSA (bovine serum albumin), while in dirty condition 0.3% BSA was used (see table 2 below).
- BSA bovine serum albumin
- the contact time was 5 min. A 5 log reduction was required to pass the test.
- compositions as used are given in table 1 below.
- the polymer complex comprised PAA (poly acrylic acid; Mw 100,000 D, ex Sigma-Aldrich) and PEO (poly ethylene oxide; Mw 100,000 D, ex Sigma-Aldrich), in a total amount as given in the table.
- Table 2 E. coli S. aureus P . aeruginosa E.
- Example 2 Long Lasting hygiene challenge.
- compositions were used (as is) Comp C (%w) Comp D (%w) Example 2 (%w) Thymol 0.025 0.025 Terpineol 0.05 0.05 Eugenol 0.005 0.005 Poly acrylic acid 1) 0.015 0.015 Poly ethylene oxide 1) 0.01 0.01 Isopropanol 0.65 0.65 Curcuma extract 0.005 0.005 Benzalkonium chloride 0.15 0.15 Citric acid 0.02 0.02 Water Up to 100% Up to 100% Up to 100% 1)
- the polymer complex comprised PAA (poly acrylic acid; Mw 100,000 D, ex Sigma-Aldrich) and PEO (poly ethylene oxide; Mw 100,000 D, ex Sigma-Aldrich), in a total amount as given in the table, or its individual components.
- compositions according to the invention still provides anti-microbial activity to the surface, even though the single ingredients do not show the same effect.
- Example 3 Long Lasting hygiene challenge.
- compositions were used (as is) Comp E (%w) Example 3 (%w) Example 4 2) (%w) Thymol 0.025 0.025 Terpineol 0.05 0.05 Eugenol 0.005 0.005 Poly acrylic acid 1) 0.015 0.015 0.015 Poly ethylene oxide 1) 0.01 0.01 0.01 C12-EO5 Nonionic 0.15 0.15 Benzalkonium chloride 0.15 Citric acid 0.02 0.02 Water Up to 100% Up to 100% Up to 100% 1)
- the polymer complex comprised PAA (poly acrylic acid; Mw 100,000 D, ex Sigma-Aldrich) and PEO (poly ethylene oxide; Mw 100,000 D, ex Sigma-Aldrich), in a total amount as given in the table, or its individual components. 2) Comparative
- compositions according to the invention still provides anti-microbial activity to the surface, even though the single ingredients do not show the same effect.
- the additional benefit of benzalkonium chloride is also demonstrated.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
Description
- The invention is in the field of hard surface cleaning, especially in the field of hard surface cleaning composition having anti-microbial effect.
- Hygiene is of high priority to present day consumers. Consumers all over the world use various kinds of disinfecting cleaning compositions for hard surfaces.
- Many micro organisms found on household surfaces are harmless, but there are also various pathogenic types or sub-species present, such as Escherichia coli, also referred to a E. coli, and Staphylococcus aureus, also referred to as S. aureus. Several other gram-positive and gram-negative bacteria can be found on any household surface.
- Therefore present day consumers appreciate hard surface cleaning products that have anti-microbial activity.
- The most commonly known disinfectant in house hold care is hypochlorite. However hypochlorite causes bad smell, bleaches clothes that come in contact with it and is unpleasant to skin mostly caused by its high alkalinity.
- Various alternative hygiene materials have been proposed in the art. In recent years a number of publications have been made on the use of essential oils for anti-bacterial action.
-
EP-A-912678 - However, essential oils are relatively expensive ingredients. Additionally, essential oils are also known for their fragrances; using high amounts may cause a peculiar smell that is not always appreciated by the consumer.
-
WO1998/20735 -
US 2007/0238634 (Foland et.al) describes a treatment formulation comprising of an active material selected from the group consisting of a surfactant, a fragrance, a dye and a combination thereof, and an ionically cross linked polymer for incorporation into nonwoven substrates. The Application doesn't disclose a composition comprising a polymer complex and an antimicrobial composition. - It is further desired that the hygiene benefit is not only active shortly after deposition, but remains on the surface for a longer time.
- Accordingly it remains to be desired to prepare hard surface cleaning composition having a high anti-microbial effect, even with a low dosage of anti-microbial essential oils.
- It is therefore an object of the invention to provide a hard surface cleaning composition, having good anti-microbial properties, at low levels of essential oil.
- It is therefore another object of the invention to provide a hygiene benefit is not only active shortly after deposition, but remains on the surface for a longer time.
- It is a further object of the invention to provide a composition that is effective against common bacteria, including both gram-positive and gram-negative bacteria. Surprisingly it has been found that composition comprising a low amount of essential oil and quaternary ammonium biocide and a polymer complex provides improved hygiene efficacy.
- Accordingly the present invention provides in a first aspect a hard surface treatment composition comprising a polymer complex comprising polymer A selected from the group of homopolymers and copolymers of carboxylic acid, and a polymer B selected from the group of homopolymers and copolymers of alkylene oxides, vinyl pyrrolidone; and/or the group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose, wherein polymer A and polymer B are not of the same class and wherein Polymer B has a monomeric unit comprising a group that forms hydrogen bonds with the carboxyl groups of polymer A; and an antimicrobial composition comprising essential oil and a quaternary ammonium biocide, wherein the pH of the hard surface treatment composition is between 2 and less than 6.
- In a second aspect the invention provides a method for providing an anti-microbial effect to a hard surface comprising the steps of applying a composition according to the first aspect to the surface, and waiting for at least 5 seconds.
- In a third aspect the invention provides the use of a combination of a polymer complex comprising polymer A selected from the group of homopolymers and copolymers of carboxylic acid, and a polymer B selected from the group of homopolymers and copolymers of alkylene oxides, vinyl pyrrolidone; and/or the group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose; wherein polymer A and polymer B are not of the same class and wherein polymer B has a monomeric unit comprising a group that forms hydrogen bonds with the carboxyl groups of polymer A; and an antimicrobial composition comprising essential oil and a quaternary ammonium biocide, wherein the pH of the hard surface treatment composition is between 2 and less than 6, for providing a anti-microbial effect on hard surfaces.
- By anti-microbial effect is meant being able to kill bacteria under the standard European suspension test (EST) - EN 1276.
- These and other aspects, features and advantages will become apparent to those of ordinary skill in the art from a reading of the following detailed description and the appended claims. For the avoidance of doubt, any feature of one aspect of the present invention may be utilised in any other aspect of the invention. The word "comprising" is intended to mean "including" but not necessarily "consisting of" or "composed of." In other words, the listed steps or options need not be exhaustive. It is noted that the examples given in the description below are intended to clarify the invention and are not intended to limit the invention to those examples per se. Similarly, all percentages are weight/weight percentages unless otherwise indicated. Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material or conditions of reaction, physical properties of materials and/or use are to be understood as modified by the word "about". Numerical ranges expressed in the format "from x to y" are understood to include x and y. When for a specific feature multiple preferred ranges are described in the format "from x to y", it is understood that all ranges combining the different endpoints are also contemplated.
- The composition according to the invention thus comprises a polymer complex and an antimicrobial composition.
- The polymer complex according to the invention comprises a polymer A selected from the group of homopolymers and copolymers of carboxylic acid, and a polymer B selected from the group of homopolymers and copolymers of alkylene oxides, vinyl pyrrolidone ; and/or the group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose ;
- The composition according to the invention comprises a polymer A and a polymer B. Polymers A and B are typically selected such that they form a complex due to the formation of hydrogen bonds.
- The polymers may be homo polymers or copolymers, wherein by copolymer of monomer X is meant any polymer that contains the monomer X and at least one further monomer.
- Polymers A and B are preferably present in the composition in a ratio of between 1:5 and 5:1, more preferably between 1:2 and 2:1
- According to the present invention, polymer A is a polymer selected from the group of homopolymers and copolymers of carboxylic acid. Polymer A has a plurality of carboxyl groups. The polymer A has a molecular mass preferably from 300 to 109 D (Dalton, also referred to as atomic mass units, amu). The polymer A is selected from the class consisting of homopolymers or copolymers of carboxylic polymers, including natural synthetic and semi-synthetic polymers in this class.
- Some non-limiting examples of polymer A according to the present invention include:
- (a) homopolymers of a carboxylic acid, including but not limited to polycarboxylic acid such as polyacrylic acid, polymaleic acid or copolymers of acrylic and maleic acid.
- (b) polysaccharides comprising carboxylic acid groups. Such polysaccharides may include (but are not limited to) sodium alginate, natural gums and sodium carboxymethyl cellulose.
- Homopolymers or copolymers of carboxylic acid have a molecular mass of preferably from 2x103 to 107 D more preferably from 5x104 to 106 D and most preferably from 9x104 to 5x105 D.
- If the polymers are in particulate form, the particle size is preferably less than 200µm, preferably less than 100µm, more preferably less than 50µm still more preferably less than 10µm, or even less than 5µm.
- The homopolymers or copolymers of polysaccharide have a molecular mass of preferably from 103 to 109 D, more preferably from 104 to 109 D and most preferably from 105 to 109 D.
- Polymer A is preferably at least partially neutralised in the Sodium (Na+) form, preferably at least 10%w of polymer A is neutralised, more preferably at least 20%, still more preferably at least 50%.
- Polymer A may be synthetic, semi-synthetic or natural. However, synthetic or semi-synthetic polymers are preferred.
- Polymer A is preferably water soluble or water dispersible, most preferably polymer A is water soluble.
- The polymer A is selected from a class consisting of homopolymers or copolymers of carboxylic acid.
- The homopolymers or copolymers of carboxylic acid are preferably a polyacrylic acid or a copolymer thereof. Examples include SOKALAN® PA (BASF) and CARBOPOL® (Lubrizol).
- The concentration of polymer A in the composition according to the invention is preferably between 0.001 and 25% by weight, more preferably at least 0.002%, or even at least 0.005%, but preferably not more than 15%, more preferably less than 5%, still more preferably less than 1%, even more preferably less than 0.5%, even less than 0.1%, or even less than 0.05% by weight of the composition.
- According to the present invention, polymer B has a monomeric unit comprising a group that forms hydrogen bonds with the carboxyl groups of polymer A.
- Accordingly, polymer B is selected from the group of homopolymers and copolymers of alkylene oxides, vinyl pyrrolidone; and/or the group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose.
- The group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose, is generally not water soluble. In order to obtain the benefit of this group of polymers the particle size is set such that the particles are easily dispersible in water or and aqueous solution (i.e. a wash or rinse liquor). If the polymers are in particulate form, the particle size is preferably less than 200µm, more preferably less than 100µm, even more preferably less than 50µm still more preferably less than 10µm, or even less than 5µm.
- According to an essential aspect, polymer A and polymer B are not of the same class. Polymers A and B are selected from different classes of polymers. Without wishing to be limited by theory, it is believed that the two polymers A and B, when dissolved in water, form a complex with a solubility lower than each of the polymers A and B, which helps in enhanced deposition and other benefits.
- Polymer B preferably has a molecular mass from 103 to 109 D.
- Homopolymers or copolymers of vinyl pyrrolidone or vinyl alcohol preferably have a molecular mass of between 103 and 107 D, more preferably from 104 to 106 D and most preferably from 30,000 to 500,000 D. Commercially available polyvinyl pyrrolidone can be used, one example of which is LUVISKOL® (BASF).
- Homopolymers or copolymers of poly alkylene oxide preferably have a molecular mass greater than 2x104 D. The molecular mass is preferably from 2x104 to 106 D, more preferably from 3x104 to 5x105 D and most preferably from 5x104 to 2x105 D.
- Homopolymers or copolymers of saccharide preferably have a molecular mass of preferably from 103 to 109 D, more preferably from 104 to 109 D and most preferably from 105 to 109 D. Any commercially available poly alkylene oxide, for example POLYOX® (Dow Chemical Co) can be used according to the present invention.
- Polymer B may be synthetic, semi-synthetic or natural. However, synthetic or semi-synthetic polymers are preferred.
- According to a preferred embodiment, the polymer B is water soluble.
- It is particularly preferred that the polymer B is selected from a class consisting of homopolymers or copolymers of vinyl pyrrolidone or alkylene oxide.
- The concentration of polymer B in the composition according to the invention is preferably between 0.001 and 20% by weight, more preferably at least 0.002%, or even at least 0.005%, but preferably not more than 10%, more preferably less than 5%, still more preferably less than 1%, even more preferably less than 0.5%, even less than 0.1 %, or even less than 0.05% by weight of the composition.
- Some examples of combinations of polymer A and polymer B, which are particularly preferred, are given below.
Table 1: Preferred combination of the polymers Polymer A Polymer B Polyacrylic acid (PAA) Poly vinyl pyrrolidone (PVP) Polyacrylic acid (PAA) Polyethylene Oxide(PEO) Polyacrylic acid (PAA) Polyethylene Glycol (PEG) Polyacrylic acid (PAA) Poly vinyl alcohol (PVA) Sodium carboxymethyl cellulose (SCMC) Polyethylene Oxide (PEO) Polyacrylic acid(PAA) Hydroxyethyl cellulose Starch-graft-polymethacrylic acid Polyethylene Oxide Starch-graft-polymethacrylic acid Polyvinyl pyrrolidone Pluronic-g-Polyacrylic acid Polyethylene Oxide Pluronic-g-Polyacrylic acid Polyvinyl pyrrolidone Sodium carboxymethyl cellulose Hydroxyethyl cellulose Sodium carboxymethyl cellulose Polyvinyl alcohol - The most preferred combinations of the polymers are PAA-PVP, PAA-PEO, PAA-PEG Starch-graft-polymethacrylic acid-Polyethylene Oxide.
- The polymer complex according to the invention comprises an antimicrobial composition comprising essential oil and quaternary ammonium biocide.
- Essential oils are typically concentrated, hydrophobic liquid containing volatile aroma compounds from plants. Essential oils are also known as volatile, ethereal oils or aetherolea. An oil is "essential" in the sense that it carries a distinctive scent, or essence, of the plant. Essential oils do not as, a group, need to have any specific chemical properties in common, beyond conveying characteristic fragrances. Essential oils may also be obtained though synthetic or semi-synthetic routes.
- Essential oils are generally extracted by distillation. Other processes include expression, or solvent extraction. They are used in perfumes, cosmetics, soap and other products, for flavoring food and drink, and for scenting incense and household cleaning products.
- Examples of aromatic essential oils suitable for use in the present invention include amyl salicylate, carvacrol, cymene, e.g. p-cymene, dihydroeugenol, eugenol, hexyl eugenol, hexyl salicylate, isoeugenol, methyl eugenol, methyl isoeugenol, methyl salicylate, tert butyl cresol, thymol, and vanillin. Examples of non-aromatic essential oils of terpenoid compounds include cedrene, cineole, citral (including geranial and neral), citronellal, citronellol, eucalyptol (also known as 1,8 cineole) paradihydrolinalool, dihydromyrcenol (DH myrcenol), farnesol, geraniol, hexyl cinnamaldehyde, hydroxycitronallol, hydroxycitronellal, isocitral, limonene, preferably d-limonene, linalool, longifolene, menthol, nerol, nerolidiol, pinene, e.g. α-pinene, phellendrene, terpinene, e.g. α-terpinene and γ-terpinene, terpineol, e.g. γ-terpineol and terpin-4-ol, and tetrahydromyrcenol (THM).
- The most preferred essential oils in the context of the present invention are thymol, terpineol and eugenol.
- The essential oil is preferably present in the composition in a concentration of between 0.001 and 10% by weight of the composition, but preferably at least 0.002%, or even at least 0.005% by weight of the composition, while preferably not more than 5%, more preferably not more than 1%, still more preferably not more than 0.5%, or even not more than 0.1% by weight of the concentration.
- It is preferred that the composition comprises a second essential oil, wherein the essential oils are even more preferably selected from any combination of a thymol, a terpineol and/or a eugenol.
- It is even more preferred that the composition comprises three essential oils, wherein the essential oils are still more preferably selected from a combination of a thymol, a terpineol and a eugenol.
- When more than one essential oil is present in the composition, the above mentioned concentrations may be considered to be the concentrations of the combined essential oils, but preferably relate to each of the individual essential oils.
- A quaternary ammonium biocide is used to provide additional biocidal efficacy. The quaternary ammonium biocide is preferably selected from Cetyl-trimethyl-ammonium Chloride, Cetyl-trimethyl-ammonium Bromide, Tetradecyl-trimethyl-ammonium Chloride, Dodecyl-trimethyl-ammonium Chloride, Stearyl-trimethyl-ammonium Chloride, Octadecyl-trimethyl-ammonium Chloride, Dodecylpyridinium Chloride, Cetylpyridinium Chloride, Benzalkonium Chloride, Tetrabutyl-ammonium Chloride, Tetraheptyl-ammonium Chloride, 1,3-Decyl-2-methyl-imidazolium Chloride, 1-Hexadecyl-3-methyl-imidazolium Chloride, Didecyl-dimethyl-ammonium Bromide, Didecyl-dimethyl-ammonium Chloride.
- Bromides are typically not preferred due to their toxicity.
- The most preferred quaternary ammonium biocide is benzalkonium chloride and cetylpyridinium chloride.
- The quaternary ammonium biocide is preferably present in the composition in a concentration of between 0.01 and 10% by weight of the composition, but preferably at least 0.02%, or even at least 0.05% by weight of the composition, while preferably not more than 5%, more preferably not more than 1%, still more preferably not more than 0.5%, or even not more than 0.1% by weight of the concentration.
- The quaternary ammonium biocide provides more complete kill with longer lasting hygiene.
- The compositions according to the invention may be applied in various hard surface cleaning composition, such as concentrated and dilute liquid compositions.
- Concentrated composition include amongst other floor cleaner composition that need to be diluted by the consumers upon use. For this kind of composition, the above mentioned concentrations are relating to the diluted concentrations as used by the consumer.
- Dilute liquid compositions include but are not limited to ready-to-use compositions, such as liquid abrasive cleaners and toilet cleaning compositions, and spray compositions for glass, kitchen surfaces and bathroom surfaces
- It is preferred that the contact time of the product with the surface before rinsing is at least 5 seconds, more preferably at least 10 seconds, still more preferably at least 15 seconds, or even at least 20 seconds.
- Stay on compositions, may stay for a longer period of time, preferably at least 5 minute, more preferably at least 15 minutes, still more preferably at least 1 hour, still more preferably at least 2 hours, or even more than 5 hours, or even days.
- The pH of the compositions is between pH 2 and less than pH 6, still more preferably at least pH 3.
- Consequently there is provided a method for providing an anti-microbial effect to hard surfaces comprising the steps of applying a composition according to the invention to the surface, waiting for at least 5 seconds.
- It is preferred that the composition is not wiped away or rinsed, but may be wiped of after the indicated time.
- The invention will now be illustrated by means of the following non-limiting examples.
- The standard European suspension test (EST) protocol - EN 1276 for antiseptics was followed. The test organisms were Pseudomonas aeruginosa, Escherichia coli, Staphylococcus aureus, and Enterococcus hirae. Under clean conditions the test was done with 0.03% BSA (bovine serum albumin), while in dirty condition 0.3% BSA was used (see table 2 below). The contact time was 5 min. A 5 log reduction was required to pass the test.
- The compositions as used are given in table 1 below.
Table 1 Comparative A (%w) Comparative B (%w) Example 12) (%w) PAA 1) 0.015 0.015 PEO 1) 0.01 0.01 Thymol 0.025 0.025 Terpineol 0.05 0.05 Eugenol 0.005 0.005 1) The polymer complex comprised PAA (poly acrylic acid; Mw 100,000 D, ex Sigma-Aldrich) and PEO (poly ethylene oxide; Mw 100,000 D, ex Sigma-Aldrich), in a total amount as given in the table. Table 2 E. coli S. aureus P. aeruginosa E. hirea clean dirty clean dirty clean dirty clean dirty Comparative A Failed Comparative B Failed Example 12) Passed The test results against the individual organisms are given below. EST - E.coli (5 min contact time) Sample Avg.cfu/ml Log Reduction Clean Dirty Clean Dirty E.coli 135000000 125000000 0.0 0.0 Comparative B 4700000 17500000 1.4 0.8 Comparative A 130000000 128000000 0.0 0.0 Example 12) 0.0 0.0 8.1 8.0 EST- S.aureus (5 min contact time) Sample Avg.cfu/ml Log Reduction Clean Dirty Clean Dirty S.aureus 4000000 4000000 0.0 0.0 Comparative B 2700000 2800000 0.2 0.2 Example 1 4.0 0.0 6.0 6.6 EST - P.aeruginosa (5 min contact time) Sample Avg.cfu/ml Log Reduction Clean Dirty Clean Dirty P.aeruginosa 11000000 7300000 0.0 0.0 Comparative B 870000 3900000 1.1 0.3 Example 1 0.0 0.0 7.0 6.9 EST - Enterococcus hirae (5 min contact time) Sample Avg.cfu/ml Long Reduction Clean Dirty Clean Dirty E. hirae 3300000 2400000 0 0 Comparative B 2200000 2400000 0.2 0 Example 1 0.0 0.0 6.5 6.4 2) Comparative - The results above show that very high reduction of bacteria is achieved with the compositions according to the inventions, while the single components do not achieve even a remotely similar effect.
- In this example a multi day test has been done.
- The following compositions were used (as is)
Comp C (%w) Comp D (%w) Example 2 (%w) Thymol 0.025 0.025 Terpineol 0.05 0.05 Eugenol 0.005 0.005 Poly acrylic acid 1) 0.015 0.015 Poly ethylene oxide 1) 0.01 0.01 Isopropanol 0.65 0.65 Curcuma extract 0.005 0.005 Benzalkonium chloride 0.15 0.15 Citric acid 0.02 0.02 Water Up to 100% Up to 100% Up to 100% 1) The polymer complex comprised PAA (poly acrylic acid; Mw 100,000 D, ex Sigma-Aldrich) and PEO (poly ethylene oxide; Mw 100,000 D, ex Sigma-Aldrich), in a total amount as given in the table, or its individual components. -
- Clean ceramic tiles of 10 by 10 cm are washed with Isopropanol (IPA, 70%) and dried.
- 10 microliter of a 108 cfu/ml E.coli (ATCC 10536) suspension was spread over the tile and dried.
- 1 ml of the fest formulations of the table above was spread over the tiles and left for 10 minutes and the tiles were dried afterwards.
- The tiles were left overnight under moist conditions
-
- The tiles were wiped with one wet wipe (DM water only) and one dry wipe.
- Rinsed with water and left to dry
- Left over night under moist conditions
-
- 10 microliter of a 108 cfu/ml E.coli suspension was spread over the tile and dried.
- The tiles were wiped with one wet wipe (DM water only) and one dry wipe.
- 10 microliter of a 108 cfu/ml E.coli suspension was spread over the tile and dried for 10 min
- 0.5 ml of a neutraliser (D/E Neutraliser) was spread over the tile and left for 5 min
- Neutraliser was collected from the tiles
- Collected neutraliser liquid was serially diluted and plated on CY Agar plate from HiMedia.
- Test results (n=3) are given below
Blank Comp C Comp D Example 2 Start colonies (E.coli) 2.8x106 2.8x106 2.8x106 2.8x106 Colonies in collected neutraliser 2.8x106 2.8x106 2.1x106 0 Log reduction 0.0 0.0 0.1 6.4 - The above results show that even after 2 days, the compositions according to the invention still provides anti-microbial activity to the surface, even though the single ingredients do not show the same effect.
- In this example a multi day test has been done as in example 2, but using different compositions.
- The following compositions were used (as is)
Comp E (%w) Example 3 (%w) Example 42) (%w) Thymol 0.025 0.025 Terpineol 0.05 0.05 Eugenol 0.005 0.005 Poly acrylic acid 1) 0.015 0.015 0.015 Poly ethylene oxide 1) 0.01 0.01 0.01 C12-EO5 Nonionic 0.15 0.15 Benzalkonium chloride 0.15 Citric acid 0.02 0.02 Water Up to 100% Up to 100% Up to 100% 1) The polymer complex comprised PAA (poly acrylic acid; Mw 100,000 D, ex Sigma-Aldrich) and PEO (poly ethylene oxide; Mw 100,000 D, ex Sigma-Aldrich), in a total amount as given in the table, or its individual components.
2) Comparative - Test results (n=3) are given below
Blank Comp E Example 3 Example 42) Start colonies (E.coli) 2.8x106 2.8x106 2.8x106 2.8x106 Colonies in collected neutraliser 2.8x106 2.8x106 60 1100 Log reduction 0.0 0.0 4.6 3.4 2) Comparative - The above results show that even after 2 days, the compositions according to the invention still provides anti-microbial activity to the surface, even though the single ingredients do not show the same effect. The additional benefit of benzalkonium chloride is also demonstrated.
Claims (9)
- A hard surface treatment composition comprising:a a polymer complex comprisingi polymer A selected from the group of homopolymers and copolymers of carboxylic acid, andii a polymer B selected from the group of homopolymers and copolymers of alkylene oxides, vinyl pyrrolidone; and/or the group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose,wherein polymer A and polymer B are not of the same class and wherein polymer B has a monomeric unit comprising a group that forms hydrogen bonds with the carboxyl groups of polymer A; andb an antimicrobial composition comprising:wherein the pH of the hard surface treatment composition is between 2 and less than 6.i essential oil; andii quaternary ammonium biocide,
- A composition according to any one of claims 1 wherein polymer A is present in a concentration of between 0.001 and 25% by weight of the composition.
- A composition according to any one of claim 1 to 2, wherein polymer B is present in a concentration of between 0.001 and 20% by weight by weight of the composition.
- A composition according to any one of claim 1 to 3, wherein the essential oil is present in a concentration of between 0.001 and 10% by weight of the composition.
- A composition according to any one of the preceding claims, wherein the composition further comprises a second essential oil, preferably a second and a third essential oil.
- A composition according to any one of the preceding claims, wherein the essential oil is selected from amyl salicylate, carvacrol, cymene, e.g. p-cymene, dihydroeugenol, eugenol, hexyl eugenol, hexyl salicylate, isoeugenol, methyl eugenol, methyl isoeugenol, methyl salicylate, tert butyl cresol, thymol, vanillin, cedrene, cineole, citral (including geranial and neral), citronellal, citronellol, eucalyptol (also known as 1,8 cineole) paradihydrolinalool, dihydromyrcenol (DH myrcenol), farnesol, geraniol, hexyl cinnamaldehyde, hydroxycitronallol, hydroxycitronellal, isocitral, limonene, preferably d-limonene, linalool, longifolene, menthol, nerol, nerolidiol, pinene, e.g. α-pinene, phellendrene, terpinene, e.g. α-terpinene and γ-terpinene, terpineol, e.g. γ-terpineol and terpin-4-ol, and tetrahydromyrcenol (THM).
- A method for providing an anti-microbial effect to a hard surface comprising the steps of:a applying a composition according to any one of claim 1 to 6 to the surface, andb waiting for at least 5 seconds.
- A method according to claim 7, wherein the composition is wiped of the surface or rinsed of the surface after step 'b'.
- Use of a combination ofa a polymer complex comprisingi polymer A selected from the group of homopolymers and copolymers of carboxylic acid, andii a polymer B selected from the group of homopolymers and copolymers of alkylene oxides, vinyl pyrrolidone; and/or the group of homopolymers and copolymers of vinyl alcohol, saccharides, hydroxyalkyl cellulose; andwherein polymer A and polymer B are not of the same class and wherein polymer B has a monomeric unit comprising a group that forms hydrogen bonds with the carboxyl groups of Polymer A; andb an antimicrobial composition comprisingwherein the pH of the hard surface treatment composition is between 2 and less than 6, for providing an anti-microbial effect on hard surfaces.i essential oil; andii quaternary ammonium biocide,
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL11719579T PL2576747T3 (en) | 2010-05-31 | 2011-05-17 | Hard surface treatment composition |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1652MU2010 | 2010-05-31 | ||
EP10169776 | 2010-07-16 | ||
PCT/EP2011/057930 WO2011151169A1 (en) | 2010-05-31 | 2011-05-17 | Hard surface treatment composition |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2576747A1 EP2576747A1 (en) | 2013-04-10 |
EP2576747B1 true EP2576747B1 (en) | 2014-04-23 |
Family
ID=45066199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11719579.2A Active EP2576747B1 (en) | 2010-05-31 | 2011-05-17 | Hard surface treatment composition |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2576747B1 (en) |
CN (1) | CN102906237B (en) |
AR (1) | AR081502A1 (en) |
BR (1) | BR112012028719B1 (en) |
EA (1) | EA020708B1 (en) |
PL (1) | PL2576747T3 (en) |
WO (1) | WO2011151169A1 (en) |
ZA (1) | ZA201208409B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102186341B (en) | 2008-10-20 | 2013-12-25 | 荷兰联合利华有限公司 | Antimicrobial composition |
EP2480090B1 (en) | 2009-09-24 | 2013-11-06 | Unilever NV | Disinfecting agent comprising eugenol, terpineol and thymol |
WO2011151172A2 (en) | 2010-05-31 | 2011-12-08 | Unilever Nv | Skin treatment composition |
US9408870B2 (en) | 2010-12-07 | 2016-08-09 | Conopco, Inc. | Oral care composition |
IN2014MN00808A (en) | 2011-11-03 | 2015-09-04 | Unilever Plc | |
ES2556981T3 (en) * | 2012-04-24 | 2016-01-21 | Enthone Inc. | Composition of chemical pre-attack and chemical attack process for plastic substrates |
CN106367229A (en) * | 2016-08-26 | 2017-02-01 | 广西棕海园林工程有限公司 | Efficient tile surface detergent as well as preparation method and use method thereof |
CN107523442A (en) * | 2017-07-29 | 2017-12-29 | 马鞍山市康辉纸箱纸品有限公司 | A kind of stupefied groove cleaning agent of Corrugator roller |
EP3572489A1 (en) | 2018-05-24 | 2019-11-27 | The Procter & Gamble Company | Spray container comprising a detergent composition |
EP3572493A1 (en) * | 2018-05-24 | 2019-11-27 | The Procter & Gamble Company | Spray container comprising a detergent composition |
EP3572492A1 (en) | 2018-05-24 | 2019-11-27 | The Procter & Gamble Company | Fine mist hard surface cleaning spray |
EP3572491B1 (en) | 2018-05-24 | 2025-02-19 | The Procter & Gamble Company | Spray container comprising a detergent composition |
EP3572490A1 (en) | 2018-05-24 | 2019-11-27 | The Procter & Gamble Company | Spray container comprising a detergent composition |
US20200179299A1 (en) * | 2018-12-07 | 2020-06-11 | Global Biolife Inc. | Composition and method of controlling infectious diseases with functional fragrances |
BR112022017867A2 (en) * | 2020-03-13 | 2022-11-01 | Unilever Ip Holdings B V | UNIT DOSE CLEANING COMPOSITION, METHOD OF PREPARING A UNIT DOSE CLEANING COMPOSITION, METHOD OF CLEANING A SUBMERGED SURFACE AND USE OF THE COMPOSITION |
WO2021257970A1 (en) * | 2020-06-19 | 2021-12-23 | Aire Fresco | Compositions and methods for sanitizing and disinfecting environments |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5437810A (en) * | 1994-04-26 | 1995-08-01 | Colgate-Palmolive Co. | Aqueous liquid detergent compositions containing oxidized polysaccharides |
CN1173127A (en) * | 1994-12-06 | 1998-02-11 | 普罗克特和甘保尔公司 | Shelf stable skin cleansing liquid with gel forming polymer and lipid |
GB9613967D0 (en) | 1996-07-03 | 1996-09-04 | Unilever Plc | Improvements relating to antimicrobial cleaning compositions |
EP0842604A1 (en) * | 1996-11-13 | 1998-05-20 | The Procter & Gamble Company | Sprayable disinfecting compositions and processes for disinfecting surfaces therewith |
US7012053B1 (en) * | 1999-10-22 | 2006-03-14 | The Procter & Gamble Company | Fabric care composition and method comprising a fabric care polysaccharide and wrinkle control agent |
US7612029B2 (en) | 2006-04-11 | 2009-11-03 | The Clorox Company | Controlled release using gels in a melamine foam |
EP2033626A3 (en) * | 2007-09-05 | 2010-03-17 | Basf Se | Imidazoliumalkyl(meth)acrylate polymers |
-
2011
- 2011-05-17 EP EP11719579.2A patent/EP2576747B1/en active Active
- 2011-05-17 PL PL11719579T patent/PL2576747T3/en unknown
- 2011-05-17 EA EA201201618A patent/EA020708B1/en not_active IP Right Cessation
- 2011-05-17 BR BR112012028719-2A patent/BR112012028719B1/en not_active IP Right Cessation
- 2011-05-17 WO PCT/EP2011/057930 patent/WO2011151169A1/en active Application Filing
- 2011-05-17 CN CN201180026526.1A patent/CN102906237B/en not_active Expired - Fee Related
- 2011-05-30 AR ARP110101847A patent/AR081502A1/en active IP Right Grant
-
2012
- 2012-11-08 ZA ZA2012/08409A patent/ZA201208409B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA201208409B (en) | 2014-01-29 |
CN102906237B (en) | 2014-10-29 |
EA020708B1 (en) | 2015-01-30 |
BR112012028719A2 (en) | 2016-07-19 |
AR081502A1 (en) | 2012-09-19 |
CN102906237A (en) | 2013-01-30 |
BR112012028719B1 (en) | 2020-12-01 |
EP2576747A1 (en) | 2013-04-10 |
EA201201618A1 (en) | 2013-04-30 |
PL2576747T3 (en) | 2014-09-30 |
WO2011151169A1 (en) | 2011-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2576747B1 (en) | Hard surface treatment composition | |
US20130061865A1 (en) | Skin treatment composition | |
EP3223612B1 (en) | Surface disinfectant with residual biocidal property | |
US7465697B1 (en) | Essential oils based cleaning and disinfecting compositions | |
CN103890160B (en) | A kind of liquid hard-surface antibacterial cleansing composition | |
JP6251787B1 (en) | Disinfecting sheet | |
CN101861379A (en) | Formulations comprising antimicrobial compositions | |
US20070082935A1 (en) | Method for disinfecting or sanitizing a surface | |
EP2780438B1 (en) | A liquid hard surface antimicrobial cleaning composition | |
EP2575744B1 (en) | Skin treatment composition | |
CN112852556B (en) | Household sterilizing, cleaning and mite-removing wet tissue | |
WO2022038630A1 (en) | Surface cleaning composition and use thereof | |
JP5769570B2 (en) | Biofilm remover, biofilm removal composition, and biofilm removal method | |
JP4781663B2 (en) | Antibacterial agent | |
KR20080089891A (en) | Multi Purpose Cleaner | |
EP2576744B1 (en) | Laundry treatment composition | |
JP7603120B1 (en) | Cleaning Sheets | |
US20100173011A1 (en) | Disinfectant cleaning composition and method | |
JP7264735B2 (en) | Hard surface treatment agent composition | |
JP6961777B1 (en) | Cleaning sheet | |
JP5982088B2 (en) | Biofilm removing agent and biofilm removing composition | |
WO2024218380A1 (en) | Laundry sanitizing compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20121016 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C11D 3/22 20060101ALI20131024BHEP Ipc: C11D 3/50 20060101ALI20131024BHEP Ipc: C11D 3/20 20060101ALI20131024BHEP Ipc: C11D 7/24 20060101ALI20131024BHEP Ipc: C11D 3/48 20060101ALI20131024BHEP Ipc: C11D 3/00 20060101AFI20131024BHEP Ipc: C11D 3/18 20060101ALI20131024BHEP Ipc: C11D 3/37 20060101ALI20131024BHEP Ipc: C11D 7/26 20060101ALI20131024BHEP |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20131218 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 663880 Country of ref document: AT Kind code of ref document: T Effective date: 20140515 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602011006386 Country of ref document: DE Effective date: 20140605 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 663880 Country of ref document: AT Kind code of ref document: T Effective date: 20140423 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20140423 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: PL Ref legal event code: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140823 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140724 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140723 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140723 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140825 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R026 Ref document number: 602011006386 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140531 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140531 |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20150130 |
|
PLAX | Notice of opposition and request to file observation + time limit sent |
Free format text: ORIGINAL CODE: EPIDOSNOBS2 |
|
26 | Opposition filed |
Opponent name: HENKEL AG & CO. KGAA Effective date: 20150123 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R026 Ref document number: 602011006386 Country of ref document: DE Effective date: 20150123 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140517 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140623 |
|
PLAF | Information modified related to communication of a notice of opposition and request to file observations + time limit |
Free format text: ORIGINAL CODE: EPIDOSCOBS2 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 |
|
PLBB | Reply of patent proprietor to notice(s) of opposition received |
Free format text: ORIGINAL CODE: EPIDOSNOBS3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20110517 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140517 |
|
PLCK | Communication despatched that opposition was rejected |
Free format text: ORIGINAL CODE: EPIDOSNREJ1 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R100 Ref document number: 602011006386 Country of ref document: DE |
|
PLBN | Opposition rejected |
Free format text: ORIGINAL CODE: 0009273 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: OPPOSITION REJECTED |
|
27O | Opposition rejected |
Effective date: 20170102 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20140423 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20210524 Year of fee payment: 11 Ref country code: DE Payment date: 20210520 Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602011006386 Country of ref document: DE Owner name: UNILEVER GLOBAL IP LIMITED, WIRRAL, GB Free format text: FORMER OWNER: UNILEVER NV, ROTTERDAM, NL |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20210525 Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20220127 AND 20220202 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20220513 Year of fee payment: 12 Ref country code: PL Payment date: 20220513 Year of fee payment: 12 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602011006386 Country of ref document: DE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20220517 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220517 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20221201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20220517 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230517 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230517 |